Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2

被引:8
作者
Azuma, Y [1 ]
Kawasaki, T [1 ]
Ohno, K [1 ]
Seto, J [1 ]
Yamada, T [1 ]
Yamasaki, M [1 ]
Nobuhara, Y [1 ]
机构
[1] Nissin Food Prod Co Ltd, Cent Res Inst, Shiga 5250055, Japan
关键词
NTE-122; acyl-CoA : cholesterol acyltransferase (ACAT) inhibitor; HepG2; cell; apolipoprotein B-containing lipoprotein secretion; bile acid secretion;
D O I
10.1254/jjp.79.151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the effect of NTE-122 (trans-1,4-bis[[l -cyclohexyl-3-(4-dimethylamino phenyl) ureido]methyl]cyclohexane), a novel acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, on intracellular cholesterol esterification and the secretion of apolipoprotein B100 (apoB)-containing lipoprotein and bile acids in the human hepatoma cell line HepG2. NTE-122 markably inhibited [H-3]oleate incorporation into cholesteryl esters in HepG2 cells incubated with 5 mu g/ml 25-hydroxycholesterol as a stimulus for ACAT (IC50 = 6.0 nM). On the other hand, NTE-122 did not affect [H-3]oleate incorporation into triglycerides and phospholipids and [C-14]acetate incorporation into cholesterol. The stimulation of ACAT by 25-hydroxycholesterol caused significant increases in the secretion of radiolabeled cholesteryl esters, radiolabeled triglycerides and apoB mass. NTE-122 pronouncedly inhibited the secretion of radiolabeled cholesteryl esters in proportion to the inhibition of cellular cholesterol esterification, and it significantly reduced the secretion of radiolabeled triglycerides and apoB mass in HepG2 cells incubated with 25-hydroxycholesterol. Furthermore, NTE-122 increased the secretion of bile acids synthesized from [C-14] cholesterol. These results suggest that NTE-122 is capable of exhibiting anti-hyperlipidemic effects by reducing both the cholesterol content and the amount of secreted very low-density lipoprotein and enhancing the excretion of bile acid from the liver.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 33 条
  • [1] Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits
    Azuma, Y
    Kawasaki, T
    Ikemoto, K
    Obata, K
    Ohno, K
    Sajiki, N
    Yamada, T
    Yamasaki, M
    Nobuhara, Y
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (03) : 355 - 364
  • [2] ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools
    Benoist, F
    GrandPerret, T
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (10) : 1229 - 1235
  • [3] REGULATION OF VLDL SECRETION IN PRIMARY CULTURE OF RAT HEPATOCYTES - INVOLVEMENT OF CAMP AND CAMP-DEPENDENT PROTEIN-KINASES
    BJORNSSON, OG
    SPARKS, JD
    SPARKS, CE
    GIBBONS, GF
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (02) : 137 - 148
  • [4] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [5] BOSTROM K, 1988, J BIOL CHEM, V263, P4434
  • [6] Acyl-coenzyme A: Cholesterol acyltransferase
    Chang, TY
    Chang, CCY
    Cheng, D
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1997, 66 : 613 - 638
  • [7] CIANFLONE KM, 1990, J LIPID RES, V31, P2045
  • [8] CRAIG WY, 1988, J BIOL CHEM, V263, P13880
  • [9] DASHTI N, 1992, J BIOL CHEM, V267, P7160
  • [10] DAVIS RA, 1982, J BIOL CHEM, V257, P2634